Nervous system cancer
MONDO:0005872A primary or metastatic malignant neoplasm involving the nervous system.
Also known as: nervous system neoplasm, neural neoplasm, neural tumor, neural tumour, tumor of the nervous system, tumour of the nervous system, cancer of nervous system, malignant neoplasm of nervous system
4638 clinical trials for this condition and its sub-types, 17 tagged with Nervous system cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Nervous system cancer
-
Central nervous system cancer 130 trials · 1,699 incl. sub-types
20 sub-types
- Malignant glioma 250 trials · 915 incl. sub-types Sub-types →
- Brain cancer 680 trials · 900 incl. sub-types Sub-types →
- Primary central nervous system lymphoma 92 trials · 103 incl. sub-types Sub-types →
- Central nervous system sarcoma 2 trials · 74 incl. sub-types Sub-types →
- Spinal cord cancer 21 trials · 57 incl. sub-types Sub-types →
- Central nervous system primitive neuroectodermal neoplasm 8 trials · 24 incl. sub-types Sub-types →
- Central nervous system Ewing sarcoma/peripheral primitive neuroectodermal tumor 1 trial · 22 incl. sub-types Sub-types →
- Malignant tumor of meninges 0 trials · 14 incl. sub-types Sub-types →
- Malignant adrenal gland pheochromocytoma 11 trials
- Central nervous system germinoma 2 trials · 4 incl. sub-types Sub-types →
- Central nervous system melanocytic neoplasm 1 trial · 4 incl. sub-types Sub-types →
- Central nervous system endodermal sinus tumor 0 trials · 1 incl. sub-types Sub-types →
- Choriocarcinoma of the central nervous system 0 trials Sub-types →
- Embryonal carcinoma of the central nervous system 0 trials Sub-types →
- Malignant carotid body paraganglioma 0 trials
- Malignant central nervous system mesenchymal, non-meningothelial neoplasm 0 trials Sub-types →
- Malignant jugulotympanic paraganglioma 0 trials
- Mixed germ cell tumor of central nervous system 0 trials Sub-types →
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
-
Sensory system cancer 0 trials · 232 incl. sub-types
7 sub-types
- Ocular cancer 10 trials · 168 incl. sub-types Sub-types →
- Tongue cancer 26 trials · 35 incl. sub-types Sub-types →
- Paranasal sinus cancer 4 trials · 24 incl. sub-types Sub-types →
- Nasal cavity cancer 5 trials · 14 incl. sub-types Sub-types →
- Auditory system cancer 0 trials · 2 incl. sub-types Sub-types →
- Malignant ear neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Optic tract astrocytoma 0 trials Sub-types →
-
Cutaneous neuroendocrine carcinoma 78 trials
-
Peripheral nervous system cancer 0 trials · 66 incl. sub-types
18 sub-types
- Malignant peripheral nerve sheath tumor 36 trials · 38 incl. sub-types Sub-types →
- Malignant adrenal gland pheochromocytoma 11 trials
- Peripheral primitive neuroectodermal tumor 7 trials · 8 incl. sub-types Sub-types →
- Ganglioneuroma 5 trials Sub-types →
- Malignant cranial nerve neoplasm 0 trials · 4 incl. sub-types Sub-types →
- Granular cell cancer 1 trial · 2 incl. sub-types Sub-types →
- Malignant perineurioma 1 trial
- Adrenal gland ganglioneuroblastoma 0 trials
- Cauda equina cancer 0 trials
- Isolated melanotic schwannoma 0 trials
- Malignant carotid body paraganglioma 0 trials
- Malignant jugulotympanic paraganglioma 0 trials
- Malignant mediastinal neural neoplasm 0 trials
- Mediastinum neuroblastoma 0 trials Sub-types →
- Neurofibroma of gallbladder 0 trials
- Neurofibroma of the heart 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
-
Ectomesenchymoma 1 trial
-
Adrenal gland neuroblastoma 0 trials
1 sub-type
- Adrenal gland ganglioneuroblastoma 0 trials
Most studied deeper sub-types
-
Can a new pill tame childhood cancers that Won't quit?
Disease control Not yet recruitingThis early-stage trial is testing an experimental drug called zanzalintinib in children and teens with solid tumors that have returned or not responded to standard treatment. The main goals are to find the highest safe dose and to see how well the drug is tolerated. Participants …
Phase 1 • Sponsor: Exelixis • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can an old alcohol-dependence drug help the immune system fight brain cancer?
Disease control Not yet recruitingThis phase 1 trial tests whether disulfiram, a drug long used for alcohol dependence, can reduce immune suppression caused by high-grade gliomas. Participants take disulfiram for 3 to 14 days before their scheduled tumor-removal surgery. The goal is to see if the drug can dampen …
Phase 1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Experimental CAR T-Cell therapy takes on recurrent brain cancer
Disease control Not yet recruitingThis early-stage trial is testing a new treatment called CHT101 for adults with aggressive brain tumors that have returned or worsened despite standard care. CHT101 is a type of immune cell therapy (CAR T-cells) designed to recognize and attack tumor cells carrying a protein call…
Phase 1 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New study aims to ease burden on families of brain injury patients
Symptom relief Not yet recruitingThis study tests a stepped-care model to support relatives of people with acquired brain injury or malignant brain tumor. The model offers basic support to all, with extra help for those who need it, based on screening. Researchers will measure changes in caregiver burden and wel…
Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New program aims to make cancer surgery safer for seniors
Knowledge-focused Not yet recruitingThis study looks at how a special program, called the Geriatric Surgery Verification Program, works at the James Cancer Hospital. The program helps doctors and nurses better care for patients aged 65 and older who need cancer surgery. It includes checking for age-related issues l…
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Personalized drug test aims to outsmart refractory brain tumors
Knowledge-focused Not yet recruitingThis study tests a lab technique called pharmacoscopy that analyzes a patient's tumor tissue to find which drugs might work best for them. It includes 40 adults with various aggressive or rare brain tumors that have not responded to standard treatments. The main goal is to see if…
Phase 2 • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
MRI vs. CT: new study aims to sharpen cancer radiotherapy
Knowledge-focused Not yet recruitingThis study tests whether using MRI scans to plan radiotherapy is better than using CT scans alone. Researchers will work with up to 150 cancer patients and 15 healthy volunteers to see if MRI can make treatment more precise and reduce side effects. The goal is to improve how tumo…
Sponsor: Swansea Bay University Health Board • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC